Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.

about

Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.

Item

http://www.wikidata.org/entity/Q47277604

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Preemptive pharmacogenetic tes ...... and perspectives of US payers.

@en

Preemptive pharmacogenetic tes ...... and perspectives of US payers.

@nl

type

Item

label

Preemptive pharmacogenetic tes ...... and perspectives of US payers.

@en

Preemptive pharmacogenetic tes ...... and perspectives of US payers.

@nl

prefLabel

Preemptive pharmacogenetic tes ...... and perspectives of US payers.

@en

Preemptive pharmacogenetic tes ...... and perspectives of US payers.

@nl

P1476

Preemptive pharmacogenetic tes ...... and perspectives of US payers.

@en

P2093

Amit S Patel

http://www.w3.org/2001/XMLSchema#string

Cyrine E Haidar

http://www.w3.org/2001/XMLSchema#string

Donna West-Strum

http://www.w3.org/2001/XMLSchema#string

James M Hoffman

http://www.w3.org/2001/XMLSchema#string

Meagen M Rosenthal

http://www.w3.org/2001/XMLSchema#string

Nicholas J Keeling

http://www.w3.org/2001/XMLSchema#string

P2860

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.

Qualitative data analysis for health services research: developing taxonomy, themes, and theory

Pharmacogenomics in the clinic

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available

Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network

Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.

Pharmacogenomics, evidence, and the role of payers.

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.

Clinical pharmacogenetics implementation: approaches, successes, and challenges

P2888

gim.2017.181

P31

scholarly article

P356

10.1038/GIM.2017.181

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29261180

http://www.w3.org/2001/XMLSchema#string

P932

5920773

http://www.w3.org/2001/XMLSchema#string